November is Lung Cancer Awareness Month, when we reflect on the tremendous progress we have made fighting this disease, and examine how best to improve patient outcomes moving forward. We've seen a significant decline in lung cancer mortality in recent decades – thanks, in part, to aggressive anti-smoking campaigns – but lung cancer remains the deadliest cancer for both men and women. Personalized medicine has the potential to reverse this trend – but only if we ensure that all advanced lung cancer patients are tested to see if a targeted treatment will help them live longer, healthier, progression-free lives.
